Scout | NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)

The NIDA Avant-Garde Award for HIV/AIDS Research is designed to support exceptionally creative scientists conducting groundbreaking research that opens new areas in HIV/AIDS related to drug abuse. The research should be innovative and transformative, differing significantly from existing work, and align with NIH HIV/AIDS research priorities. It focuses on basic research that could lead to bett…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Program: SBIR

Award

Award Ceiling: $700,000

Funding Amount: $700,000

Dates

Opportunity Released: March 20, 2023

Open for Submission: March 20, 2023

Application Window Closes: August 14, 2025

Submission Deadline: August 14, 2025

Keywords

HIV/AIDS

drug abuse

innovative research

prevention and treatment

transformative approaches

NIH research priorities

disease transmission

novel therapies

eradication strategies

Avant-Garde Award.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers